0 Комментарии
0 Поделились
2355 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- AI in the Cell and Gene Therapy Market Size, Trends, Revenue Share Analysis, Forecast, 2024–2030In the realm of medicine, particularly in the burgeoning field of cell and gene therapy, the integration of artificial intelligence (AI) is heralding a new era of innovation and precision. With the potential to transform treatment paradigms and revolutionize patient care, AI technologies are increasingly becoming indispensable tools for researchers, clinicians, and biotech companies alike....0 Комментарии 0 Поделились 2133 Просмотры 0 предпросмотр
- Gene Therapy For Rare Disease Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Rare Diseases And Increasing Adoption Of Gene TherapyMarket Overview: Gene therapy for rare diseases involves the introduction of genetic material into a patient's cells to correct the underlying genetic defects, thereby providing potential therapeutic benefits. This innovative approach has gained significant attention in recent years, as it offers a promising solution for the treatment of numerous genetic disorders that lack effective...0 Комментарии 0 Поделились 2118 Просмотры 0 предпросмотр
- "Future Prospects: Cell and Gene Therapy Biomanufacturing Market Set for 10.60% CAGR Growth through 2032"Market Growth The cell and gene therapy biomanufacturing market is witnessing unprecedented growth, driven by technological advancements, increased funding, and rising prevalence of chronic diseases. As of 2023, the market size was valued at USD 13.9 billion and is projected to reach USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.60% during the forecast period....0 Комментарии 0 Поделились 170 Просмотры 0 предпросмотр
- "Global Cell and Gene Therapy Biomanufacturing Market: Market Dynamics, Size, and Forecast Through 2032Market Growth The cell and gene therapy biomanufacturing market is witnessing unprecedented growth, driven by technological advancements, increased funding, and rising prevalence of chronic diseases. As of 2023, the market size was valued at USD 13.9 billion and is projected to reach USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.60% during the forecast period....0 Комментарии 0 Поделились 61 Просмотры 0 предпросмотр
- 2032 Gene Therapy Market Forecast Trends, Growth, and Key Players to Watch Forecast 2024-2032Gene Therapy Market Overview: According to a Market Research Future study, the Gene Therapy industry is projected to reach a valuation of USD 43.1 by the end of 2032. In addition, the report states that during the forecast period of 2024–2032, the Gene Therapy Market is expected to grow at a CAGR of 19.87%. Global Gene Therapy Industry is an in-depth study of the...0 Комментарии 0 Поделились 138 Просмотры 0 предпросмотр
- A New Hope for DMD: Sarepta’s ELEVIDYS Gene TherapySarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that primarily affects boys, leading to progressive muscle degeneration and weakness. Historically, DMD has been managed through supportive care, steroids, and emerging pharmaceutical therapies, but there has been no cure. The...0 Комментарии 0 Поделились 473 Просмотры 0 предпросмотр
- Adeno-Associated Virus Gene Therapy Market Analysis, Report, Trends & ForecastAdeno-Associated Virus (AAV) gene therapy market has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable advancements, with numerous clinical trials and FDA approvals highlighting its potential to revolutionize healthcare. This blog explores the current landscape of AAV gene therapy in the U.S.,...0 Комментарии 0 Поделились 214 Просмотры 0 предпросмотр
- Adeno-Associated Virus Vector-Based Gene Therapy Market 2024-32The Reports and Insights, a leading market research company, has recently releases report titled “Adeno-Associated Virus (AAV) vector-based gene therapy Market Share: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Adeno-Associated Virus (AAV) vector-based gene therapy...0 Комментарии 0 Поделились 385 Просмотры 0 предпросмотр
- Advancements in AAV Vectors for Gene Therapy: What’s New in 2024Adeno-associated virus (AAV) vectors have become a cornerstone in the field of gene therapy, offering a safe and efficient method for delivering therapeutic genes to target cells. AAV vectors are non-pathogenic and elicit minimal immune response, making them ideal candidates for treating a wide range of genetic disorders. As research in gene therapy continues to advance, the Adeno-Associated...0 Комментарии 0 Поделились 19 Просмотры 0 предпросмотр
- Advancements in Gene Therapy: Market Trends, Innovations, and Future ProspectsThe Gene Therapy Market size was valued at USD 8.65 Billion in 2023 and the total Gene Therapy market revenue is expected to grow at a CAGR of 16% from 2024 to 2030, reaching nearly USD 24.45 Billion by 2030. Gene Therapy Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Gene Therapy Market”. The report...0 Комментарии 0 Поделились 105 Просмотры 0 предпросмотр
Расширенные страницы